CRF initiates Harmonizing Outcomes with Revascularization and Stents in AMI II ... News-Medical.net The Cardiovascular Research Foundation (CRF) today announced the initiation of the HORIZONS-AMI II randomized trial, evaluating Promus Element platinum-chromium everolimus-eluting stents versus Omega bare-metal stents in patients with heart attack ... Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium ... ACC 2012: Boston Scientific swats stent deformation concerns |
